Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nuclear Proteins | 78 | 2024 | 5793 | 7.090 |
Why?
|
Oncogene Proteins | 40 | 2018 | 721 | 6.240 |
Why?
|
Oncogene Proteins, Fusion | 39 | 2023 | 1591 | 4.410 |
Why?
|
Carcinoma | 36 | 2023 | 2334 | 4.200 |
Why?
|
Carcinoma, Squamous Cell | 33 | 2023 | 4024 | 3.240 |
Why?
|
Neoplasm Proteins | 53 | 2024 | 3613 | 2.700 |
Why?
|
Transcription Factors | 37 | 2023 | 12100 | 2.190 |
Why?
|
Cell Cycle Proteins | 29 | 2023 | 3448 | 2.120 |
Why?
|
Gene Rearrangement | 24 | 2018 | 1122 | 1.540 |
Why?
|
E1A-Associated p300 Protein | 3 | 2020 | 123 | 1.310 |
Why?
|
Translocation, Genetic | 16 | 2018 | 1388 | 1.190 |
Why?
|
Mediastinal Neoplasms | 7 | 2016 | 402 | 1.180 |
Why?
|
In Situ Hybridization, Fluorescence | 23 | 2022 | 2500 | 1.120 |
Why?
|
Gene Fusion | 4 | 2022 | 354 | 0.900 |
Why?
|
Chromosomes, Human, Pair 15 | 9 | 2017 | 363 | 0.790 |
Why?
|
p300-CBP Transcription Factors | 2 | 2021 | 150 | 0.720 |
Why?
|
Chromosomes, Human, Pair 19 | 6 | 2017 | 347 | 0.710 |
Why?
|
Germ Cells | 2 | 2022 | 635 | 0.630 |
Why?
|
Antineoplastic Agents | 7 | 2023 | 13629 | 0.610 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2021 | 772 | 0.600 |
Why?
|
Chloride Channels | 1 | 2018 | 221 | 0.570 |
Why?
|
Chromatin | 7 | 2023 | 2939 | 0.530 |
Why?
|
Lung Neoplasms | 13 | 2023 | 13249 | 0.530 |
Why?
|
Adenocarcinoma, Follicular | 3 | 2016 | 325 | 0.500 |
Why?
|
Cell Line, Tumor | 15 | 2023 | 16905 | 0.490 |
Why?
|
Benzimidazoles | 1 | 2020 | 858 | 0.480 |
Why?
|
Pyridones | 1 | 2020 | 788 | 0.480 |
Why?
|
Head and Neck Neoplasms | 4 | 2022 | 2880 | 0.480 |
Why?
|
Acetanilides | 1 | 2016 | 169 | 0.480 |
Why?
|
High-Throughput Nucleotide Sequencing | 4 | 2021 | 3618 | 0.470 |
Why?
|
Proto-Oncogene Proteins c-myc | 3 | 2021 | 995 | 0.450 |
Why?
|
Molecular Targeted Therapy | 4 | 2021 | 2805 | 0.440 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2016 | 275 | 0.430 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2020 | 8498 | 0.430 |
Why?
|
Turbinates | 1 | 2013 | 64 | 0.420 |
Why?
|
Tumor Suppressor Proteins | 3 | 2021 | 2804 | 0.420 |
Why?
|
Laryngeal Neoplasms | 6 | 2017 | 514 | 0.400 |
Why?
|
Nasopharyngeal Neoplasms | 3 | 2011 | 286 | 0.390 |
Why?
|
Immunohistochemistry | 18 | 2022 | 11064 | 0.390 |
Why?
|
Small Molecule Libraries | 2 | 2020 | 734 | 0.390 |
Why?
|
Sarcoma | 2 | 2018 | 1786 | 0.360 |
Why?
|
Maxillary Sinus Neoplasms | 3 | 2018 | 39 | 0.360 |
Why?
|
Histone-Lysine N-Methyltransferase | 1 | 2014 | 679 | 0.340 |
Why?
|
Cell Differentiation | 10 | 2018 | 11480 | 0.340 |
Why?
|
Humans | 107 | 2024 | 760261 | 0.330 |
Why?
|
Upper Gastrointestinal Tract | 1 | 2009 | 46 | 0.320 |
Why?
|
Digestive System Neoplasms | 1 | 2009 | 81 | 0.320 |
Why?
|
Nose Neoplasms | 4 | 2012 | 249 | 0.320 |
Why?
|
Testicular Neoplasms | 2 | 2021 | 800 | 0.310 |
Why?
|
Otorhinolaryngologic Neoplasms | 1 | 2008 | 26 | 0.310 |
Why?
|
Thyroid Neoplasms | 4 | 2018 | 2332 | 0.310 |
Why?
|
Neoplasms | 9 | 2021 | 22066 | 0.310 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2023 | 11708 | 0.310 |
Why?
|
Sarcoma, Small Cell | 1 | 2007 | 17 | 0.300 |
Why?
|
Adolescent | 31 | 2024 | 87747 | 0.290 |
Why?
|
SOXB1 Transcription Factors | 3 | 2021 | 286 | 0.290 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3215 | 0.280 |
Why?
|
Fatal Outcome | 7 | 2017 | 1833 | 0.280 |
Why?
|
Cytogenetic Analysis | 2 | 2012 | 271 | 0.270 |
Why?
|
Repressor Proteins | 1 | 2017 | 2978 | 0.260 |
Why?
|
Parotid Neoplasms | 3 | 2018 | 157 | 0.260 |
Why?
|
Young Adult | 21 | 2024 | 58673 | 0.250 |
Why?
|
Cell Proliferation | 5 | 2020 | 10434 | 0.250 |
Why?
|
Rhinitis | 1 | 2013 | 747 | 0.250 |
Why?
|
Ifosfamide | 2 | 2023 | 232 | 0.250 |
Why?
|
Female | 60 | 2024 | 391011 | 0.250 |
Why?
|
Thymus Neoplasms | 2 | 2021 | 274 | 0.240 |
Why?
|
PPAR gamma | 1 | 2008 | 484 | 0.240 |
Why?
|
RNA-Binding Proteins | 5 | 2016 | 1892 | 0.230 |
Why?
|
Adult | 45 | 2024 | 219847 | 0.230 |
Why?
|
Sinusitis | 1 | 2013 | 992 | 0.220 |
Why?
|
Cell Nucleus | 5 | 2018 | 2909 | 0.220 |
Why?
|
Histones | 3 | 2023 | 2583 | 0.220 |
Why?
|
Middle Aged | 38 | 2024 | 220175 | 0.220 |
Why?
|
Male | 57 | 2024 | 359413 | 0.210 |
Why?
|
Endoscopy | 1 | 2013 | 1841 | 0.210 |
Why?
|
Thyroid Gland | 2 | 2022 | 1169 | 0.210 |
Why?
|
Aged | 29 | 2024 | 168995 | 0.210 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2011 | 2007 | 0.210 |
Why?
|
Child | 22 | 2024 | 79758 | 0.200 |
Why?
|
Tumor Cells, Cultured | 4 | 2020 | 6131 | 0.200 |
Why?
|
N-Methylaspartate | 1 | 2022 | 231 | 0.200 |
Why?
|
DNA-Binding Proteins | 3 | 2018 | 9590 | 0.200 |
Why?
|
Streptococcus pyogenes | 1 | 2024 | 294 | 0.200 |
Why?
|
Epithelial Cells | 2 | 2017 | 3665 | 0.190 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2023 | 2823 | 0.180 |
Why?
|
Azepines | 2 | 2020 | 330 | 0.180 |
Why?
|
Bone Neoplasms | 2 | 2014 | 2532 | 0.170 |
Why?
|
Dendrites | 1 | 2022 | 475 | 0.170 |
Why?
|
Streptococcal Infections | 1 | 2024 | 617 | 0.170 |
Why?
|
Tracheal Neoplasms | 1 | 2020 | 123 | 0.170 |
Why?
|
Genes, Tumor Suppressor | 1 | 2023 | 1056 | 0.160 |
Why?
|
Paranasal Sinus Neoplasms | 2 | 2016 | 241 | 0.160 |
Why?
|
Sialoglycoproteins | 1 | 2020 | 315 | 0.160 |
Why?
|
Thoracic Neoplasms | 2 | 2013 | 265 | 0.160 |
Why?
|
Abnormalities, Severe Teratoid | 1 | 1998 | 5 | 0.160 |
Why?
|
RNA, Small Interfering | 3 | 2017 | 3443 | 0.160 |
Why?
|
Lipoma | 1 | 2000 | 292 | 0.160 |
Why?
|
Survival Rate | 3 | 2023 | 12806 | 0.160 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 854 | 0.160 |
Why?
|
Aged, 80 and over | 14 | 2024 | 58947 | 0.150 |
Why?
|
Carcinoma, Papillary, Follicular | 1 | 2018 | 60 | 0.150 |
Why?
|
Diagnosis, Differential | 7 | 2022 | 12968 | 0.150 |
Why?
|
Mice | 7 | 2023 | 81216 | 0.140 |
Why?
|
Child, Preschool | 12 | 2024 | 42034 | 0.140 |
Why?
|
Phylogeny | 1 | 2024 | 2775 | 0.140 |
Why?
|
Lymphoproliferative Disorders | 1 | 2000 | 533 | 0.140 |
Why?
|
Pericardiocentesis | 1 | 2017 | 79 | 0.140 |
Why?
|
Fetal Diseases | 3 | 1998 | 911 | 0.140 |
Why?
|
Fetal Heart | 1 | 1998 | 281 | 0.140 |
Why?
|
Positron-Emission Tomography | 2 | 2017 | 6457 | 0.130 |
Why?
|
Sublingual Gland Neoplasms | 1 | 2015 | 2 | 0.130 |
Why?
|
Femoral Neck Fractures | 1 | 2017 | 141 | 0.130 |
Why?
|
Histone Chaperones | 1 | 2016 | 82 | 0.130 |
Why?
|
Proteins | 2 | 2021 | 6030 | 0.130 |
Why?
|
Tongue Neoplasms | 1 | 2017 | 183 | 0.130 |
Why?
|
Cardiac Tamponade | 1 | 2017 | 174 | 0.130 |
Why?
|
Mice, Inbred NOD | 1 | 2020 | 1837 | 0.130 |
Why?
|
Benzodiazepines | 1 | 2021 | 1132 | 0.130 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2016 | 377 | 0.130 |
Why?
|
Adenocarcinoma | 3 | 2021 | 6310 | 0.130 |
Why?
|
Disease-Free Survival | 3 | 2016 | 6830 | 0.120 |
Why?
|
Arcobacter | 1 | 2014 | 1 | 0.120 |
Why?
|
Acetylation | 3 | 2016 | 1062 | 0.120 |
Why?
|
Zinc Fingers | 1 | 2017 | 568 | 0.120 |
Why?
|
Mice, SCID | 1 | 2020 | 2627 | 0.120 |
Why?
|
Animals | 10 | 2023 | 167940 | 0.120 |
Why?
|
Adamantinoma | 1 | 2014 | 9 | 0.120 |
Why?
|
Histone Acetyltransferases | 1 | 2016 | 337 | 0.120 |
Why?
|
Carcinoma, Basal Cell | 1 | 2019 | 559 | 0.110 |
Why?
|
Transfection | 2 | 2013 | 5782 | 0.110 |
Why?
|
Femoral Neoplasms | 1 | 2014 | 81 | 0.110 |
Why?
|
Antibodies, Monoclonal | 3 | 2012 | 9196 | 0.110 |
Why?
|
Video Recording | 1 | 2018 | 957 | 0.110 |
Why?
|
Antigens, CD34 | 3 | 2011 | 652 | 0.110 |
Why?
|
Molecular Sequence Data | 7 | 2014 | 17628 | 0.110 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1137 | 0.100 |
Why?
|
Carcinoma, Papillary | 1 | 2018 | 785 | 0.100 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2018 | 927 | 0.100 |
Why?
|
Calmodulin-Binding Proteins | 1 | 2013 | 232 | 0.100 |
Why?
|
Seminoma | 1 | 2013 | 134 | 0.100 |
Why?
|
Cell Cycle | 1 | 2020 | 2937 | 0.100 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3584 | 0.100 |
Why?
|
Neck | 1 | 2016 | 730 | 0.100 |
Why?
|
Biopsy | 4 | 2018 | 6775 | 0.100 |
Why?
|
Skin Neoplasms | 3 | 2019 | 5797 | 0.100 |
Why?
|
Predictive Value of Tests | 5 | 2022 | 15273 | 0.090 |
Why?
|
HEK293 Cells | 2 | 2017 | 4264 | 0.090 |
Why?
|
Anticonvulsants | 3 | 2018 | 1881 | 0.090 |
Why?
|
Azirines | 1 | 2010 | 30 | 0.090 |
Why?
|
Sarcoma, Endometrial Stromal | 1 | 2012 | 93 | 0.090 |
Why?
|
Nasal Cavity | 2 | 2009 | 304 | 0.090 |
Why?
|
Epilepsy | 2 | 2018 | 3267 | 0.090 |
Why?
|
Dihydropyridines | 1 | 2010 | 68 | 0.090 |
Why?
|
14-3-3 Proteins | 1 | 2012 | 221 | 0.090 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2020 | 1401 | 0.090 |
Why?
|
Multiprotein Complexes | 1 | 2017 | 1120 | 0.090 |
Why?
|
Protein Structure, Tertiary | 2 | 2015 | 3800 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 4 | 2014 | 20484 | 0.090 |
Why?
|
Paired Box Transcription Factors | 1 | 2011 | 207 | 0.090 |
Why?
|
Submandibular Gland Neoplasms | 1 | 2010 | 10 | 0.090 |
Why?
|
Sleep Apnea Syndromes | 1 | 2018 | 973 | 0.090 |
Why?
|
Diagnostic Errors | 2 | 2016 | 1266 | 0.090 |
Why?
|
Flow Cytometry | 1 | 2000 | 5873 | 0.090 |
Why?
|
Treatment Outcome | 8 | 2021 | 64947 | 0.090 |
Why?
|
Biopsy, Fine-Needle | 2 | 2021 | 1111 | 0.090 |
Why?
|
Combined Modality Therapy | 6 | 2017 | 8551 | 0.080 |
Why?
|
Sequence Analysis, DNA | 2 | 2018 | 4717 | 0.080 |
Why?
|
Infant | 5 | 2024 | 36030 | 0.080 |
Why?
|
Placenta | 1 | 1998 | 1701 | 0.080 |
Why?
|
Thyroid Nodule | 1 | 2016 | 760 | 0.080 |
Why?
|
Prognosis | 8 | 2022 | 29636 | 0.080 |
Why?
|
Phenotype | 3 | 2022 | 16543 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2020 | 2218 | 0.080 |
Why?
|
Preoperative Care | 1 | 2017 | 2255 | 0.080 |
Why?
|
Enhancer Elements, Genetic | 1 | 2015 | 1356 | 0.080 |
Why?
|
Antibody Specificity | 2 | 2009 | 1061 | 0.080 |
Why?
|
RNA Interference | 1 | 2017 | 2846 | 0.080 |
Why?
|
Karyotyping | 2 | 2008 | 1172 | 0.080 |
Why?
|
Cell Survival | 1 | 2018 | 5796 | 0.080 |
Why?
|
Infant, Newborn | 5 | 2024 | 26168 | 0.080 |
Why?
|
Hydroxamic Acids | 1 | 2011 | 482 | 0.080 |
Why?
|
Tibia | 1 | 2014 | 1065 | 0.080 |
Why?
|
Lymphatic Metastasis | 4 | 2018 | 2945 | 0.070 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2012 | 487 | 0.070 |
Why?
|
Mice, Nude | 2 | 2011 | 3605 | 0.070 |
Why?
|
Orbital Neoplasms | 1 | 2009 | 221 | 0.070 |
Why?
|
Neoplasm Staging | 3 | 2016 | 11141 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2021 | 3758 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2020 | 5120 | 0.070 |
Why?
|
Anesthetics, Local | 1 | 2014 | 1001 | 0.070 |
Why?
|
Submandibular Gland | 2 | 2021 | 87 | 0.070 |
Why?
|
Histone Deacetylases | 1 | 2011 | 718 | 0.070 |
Why?
|
Chromosome Aberrations | 2 | 2012 | 1767 | 0.070 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1617 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 4 | 2022 | 17766 | 0.070 |
Why?
|
Soft Tissue Neoplasms | 1 | 2014 | 1151 | 0.060 |
Why?
|
DNA, Neoplasm | 3 | 2010 | 1745 | 0.060 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2023 | 9274 | 0.060 |
Why?
|
Aneuploidy | 2 | 2013 | 551 | 0.060 |
Why?
|
Cytodiagnosis | 2 | 2016 | 432 | 0.060 |
Why?
|
Arizona | 1 | 2024 | 109 | 0.060 |
Why?
|
Heart Diseases | 1 | 2017 | 2809 | 0.060 |
Why?
|
Models, Molecular | 2 | 2014 | 5429 | 0.060 |
Why?
|
Multigene Family | 1 | 2007 | 1079 | 0.060 |
Why?
|
Precancerous Conditions | 1 | 2011 | 978 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 9497 | 0.060 |
Why?
|
Electroencephalography | 1 | 2018 | 6182 | 0.050 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2013 | 2052 | 0.050 |
Why?
|
Rabbits | 1 | 2009 | 4773 | 0.050 |
Why?
|
Transplantation, Heterologous | 1 | 2011 | 2378 | 0.050 |
Why?
|
Expressed Sequence Tags | 1 | 2003 | 250 | 0.050 |
Why?
|
Retrospective Studies | 7 | 2018 | 80301 | 0.050 |
Why?
|
DNA Methylation | 1 | 2016 | 4374 | 0.050 |
Why?
|
Neoplasm Invasiveness | 3 | 2019 | 3618 | 0.050 |
Why?
|
Recombination, Genetic | 3 | 2018 | 1526 | 0.050 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4573 | 0.050 |
Why?
|
Remission Induction | 1 | 2007 | 2394 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6545 | 0.050 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 2024 | 407 | 0.050 |
Why?
|
False Negative Reactions | 2 | 2020 | 574 | 0.050 |
Why?
|
HeLa Cells | 1 | 2007 | 3105 | 0.050 |
Why?
|
Blotting, Southern | 1 | 2001 | 778 | 0.050 |
Why?
|
Keratins | 2 | 2013 | 497 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5640 | 0.050 |
Why?
|
alpha-Fetoproteins | 2 | 1994 | 222 | 0.050 |
Why?
|
Amino Acid Sequence | 3 | 2014 | 13456 | 0.050 |
Why?
|
Seizures | 1 | 2013 | 2916 | 0.040 |
Why?
|
Mediastinum | 1 | 2021 | 265 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2009 | 14656 | 0.040 |
Why?
|
Pyramidal Cells | 1 | 2022 | 369 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3526 | 0.040 |
Why?
|
S100 Proteins | 1 | 2000 | 218 | 0.040 |
Why?
|
Chromosomes, Human, Pair 9 | 2 | 2013 | 534 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2016 | 4312 | 0.040 |
Why?
|
Protein Binding | 4 | 2014 | 9336 | 0.040 |
Why?
|
Genome, Bacterial | 1 | 2024 | 770 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2013 | 36247 | 0.040 |
Why?
|
Health Facilities | 1 | 2024 | 578 | 0.040 |
Why?
|
Testis | 1 | 2003 | 794 | 0.040 |
Why?
|
Antigens, Bacterial | 1 | 2024 | 1155 | 0.040 |
Why?
|
Chorion | 1 | 1998 | 114 | 0.040 |
Why?
|
Sequence Alignment | 2 | 2014 | 2178 | 0.040 |
Why?
|
Cyclin T | 1 | 2017 | 19 | 0.040 |
Why?
|
Transcription, Genetic | 3 | 2017 | 7593 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2015 | 4875 | 0.040 |
Why?
|
Chronic Disease | 1 | 2013 | 9283 | 0.040 |
Why?
|
Base Sequence | 2 | 2007 | 12447 | 0.040 |
Why?
|
Genes | 1 | 2001 | 1845 | 0.040 |
Why?
|
Cerebrospinal Fluid | 1 | 2000 | 544 | 0.040 |
Why?
|
Immunoenzyme Techniques | 1 | 2000 | 1705 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 9 | 1 | 2017 | 67 | 0.040 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 893 | 0.040 |
Why?
|
Sarcoma, Synovial | 1 | 2018 | 151 | 0.040 |
Why?
|
Amnion | 1 | 1998 | 197 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2018 | 4109 | 0.040 |
Why?
|
Oncogenes | 1 | 2003 | 1221 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2001 | 1697 | 0.030 |
Why?
|
Brain Neoplasms | 2 | 2017 | 8984 | 0.030 |
Why?
|
Papillomavirus Infections | 1 | 2008 | 1600 | 0.030 |
Why?
|
Twins, Monozygotic | 1 | 1998 | 469 | 0.030 |
Why?
|
Fetal Death | 1 | 1998 | 434 | 0.030 |
Why?
|
Alternative Splicing | 1 | 2001 | 1091 | 0.030 |
Why?
|
Diseases in Twins | 1 | 1998 | 447 | 0.030 |
Why?
|
Treatment Failure | 2 | 2014 | 2646 | 0.030 |
Why?
|
Immunophenotyping | 1 | 2000 | 1870 | 0.030 |
Why?
|
Histone Code | 1 | 2016 | 157 | 0.030 |
Why?
|
World Health Organization | 1 | 2021 | 1319 | 0.030 |
Why?
|
Action Potentials | 1 | 2022 | 1814 | 0.030 |
Why?
|
Benzocaine | 1 | 2014 | 14 | 0.030 |
Why?
|
Echocardiography | 2 | 2017 | 4980 | 0.030 |
Why?
|
Prenatal Diagnosis | 2 | 1994 | 1262 | 0.030 |
Why?
|
Genome-Wide Association Study | 1 | 2013 | 12602 | 0.030 |
Why?
|
Molecular Mimicry | 1 | 1995 | 200 | 0.030 |
Why?
|
Phenytoin | 1 | 2014 | 188 | 0.030 |
Why?
|
Australia | 1 | 2017 | 1288 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2009 | 4317 | 0.030 |
Why?
|
Binding Sites | 2 | 2014 | 6050 | 0.030 |
Why?
|
Mutation | 1 | 2018 | 29950 | 0.030 |
Why?
|
Antibodies, Antinuclear | 1 | 1995 | 344 | 0.030 |
Why?
|
RNA Polymerase II | 1 | 2017 | 539 | 0.030 |
Why?
|
Down Syndrome | 2 | 1994 | 891 | 0.030 |
Why?
|
Blotting, Western | 2 | 2011 | 5039 | 0.030 |
Why?
|
SOXF Transcription Factors | 1 | 2013 | 30 | 0.030 |
Why?
|
Cough | 1 | 2017 | 595 | 0.030 |
Why?
|
Nucleosomes | 1 | 2016 | 484 | 0.030 |
Why?
|
Thermodynamics | 1 | 2014 | 599 | 0.030 |
Why?
|
Transcription Factor AP-2 | 1 | 2013 | 79 | 0.030 |
Why?
|
Membranes, Artificial | 1 | 2014 | 367 | 0.030 |
Why?
|
Genes, erbB-1 | 1 | 2013 | 160 | 0.030 |
Why?
|
Reproducibility of Results | 3 | 2018 | 20048 | 0.030 |
Why?
|
Phosphatidylinositols | 1 | 2013 | 282 | 0.030 |
Why?
|
Follow-Up Studies | 3 | 2016 | 39254 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2014 | 329 | 0.030 |
Why?
|
Chorionic Gonadotropin | 1 | 1994 | 457 | 0.030 |
Why?
|
Chromosomes, Human, Pair 6 | 1 | 2013 | 375 | 0.030 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2825 | 0.030 |
Why?
|
Radiotherapy | 2 | 2009 | 1505 | 0.020 |
Why?
|
Etoposide | 1 | 2013 | 630 | 0.020 |
Why?
|
Polysomnography | 1 | 2018 | 1817 | 0.020 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2013 | 223 | 0.020 |
Why?
|
Pancreatic Neoplasms | 1 | 2009 | 5333 | 0.020 |
Why?
|
RNA-Binding Protein EWS | 1 | 2013 | 210 | 0.020 |
Why?
|
Whole Body Imaging | 1 | 2014 | 278 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 943 | 0.020 |
Why?
|
Hospitals, Teaching | 1 | 2016 | 1166 | 0.020 |
Why?
|
Protein Structure, Secondary | 1 | 2014 | 1230 | 0.020 |
Why?
|
Genome, Human | 2 | 2016 | 4416 | 0.020 |
Why?
|
Co-Repressor Proteins | 1 | 2012 | 191 | 0.020 |
Why?
|
Consensus | 1 | 2021 | 3106 | 0.020 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2012 | 276 | 0.020 |
Why?
|
Shock, Cardiogenic | 1 | 2017 | 734 | 0.020 |
Why?
|
Disease Progression | 3 | 2014 | 13505 | 0.020 |
Why?
|
Fracture Fixation, Internal | 1 | 2017 | 964 | 0.020 |
Why?
|
Protein Subunits | 1 | 2014 | 943 | 0.020 |
Why?
|
Thyroidectomy | 1 | 2016 | 903 | 0.020 |
Why?
|
Autoantigens | 1 | 1995 | 877 | 0.020 |
Why?
|
Extracellular Matrix Proteins | 1 | 1995 | 829 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2012 | 697 | 0.020 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2012 | 419 | 0.020 |
Why?
|
Bacterial Translocation | 1 | 2009 | 73 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2010 | 618 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2011 | 551 | 0.020 |
Why?
|
Dyspnea | 1 | 2017 | 1352 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2013 | 729 | 0.020 |
Why?
|
Microscopy, Electron | 1 | 2012 | 2558 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2013 | 731 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2021 | 4409 | 0.020 |
Why?
|
Genomics | 1 | 2024 | 5790 | 0.020 |
Why?
|
Triazoles | 1 | 2014 | 904 | 0.020 |
Why?
|
Gene Expression | 2 | 2013 | 7592 | 0.020 |
Why?
|
COS Cells | 1 | 2010 | 1129 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10829 | 0.020 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2009 | 430 | 0.020 |
Why?
|
Diplopia | 1 | 2009 | 214 | 0.020 |
Why?
|
Program Development | 1 | 1994 | 1297 | 0.020 |
Why?
|
Human papillomavirus 18 | 1 | 2008 | 126 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 2014 | 1755 | 0.020 |
Why?
|
Oral Surgical Procedures | 1 | 2009 | 166 | 0.020 |
Why?
|
Cisplatin | 1 | 2013 | 1642 | 0.020 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2017 | 1403 | 0.020 |
Why?
|
Inpatients | 1 | 2018 | 2578 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2017 | 5201 | 0.020 |
Why?
|
Prospective Studies | 4 | 2016 | 54263 | 0.020 |
Why?
|
Human papillomavirus 16 | 1 | 2008 | 266 | 0.020 |
Why?
|
Age of Onset | 1 | 2013 | 3302 | 0.020 |
Why?
|
Mesoderm | 1 | 2009 | 671 | 0.020 |
Why?
|
Protein Transport | 1 | 2012 | 1966 | 0.020 |
Why?
|
Recombinant Fusion Proteins | 2 | 2010 | 3735 | 0.020 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2009 | 586 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2018 | 7016 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2008 | 1900 | 0.010 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2010 | 1790 | 0.010 |
Why?
|
Membrane Proteins | 2 | 2012 | 7854 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8553 | 0.010 |
Why?
|
Chromosomes, Human, 19-20 | 1 | 2003 | 11 | 0.010 |
Why?
|
Chromosomes, Human, 13-15 | 1 | 2003 | 49 | 0.010 |
Why?
|
Radiography | 1 | 2015 | 6965 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9282 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2013 | 2414 | 0.010 |
Why?
|
Neurons | 1 | 2022 | 9416 | 0.010 |
Why?
|
Laryngoscopy | 1 | 2008 | 706 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 2651 | 0.010 |
Why?
|
Comorbidity | 1 | 2017 | 10552 | 0.010 |
Why?
|
Proteomics | 1 | 2016 | 3810 | 0.010 |
Why?
|
Autoimmune Diseases | 1 | 1995 | 2250 | 0.010 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 1995 | 2160 | 0.010 |
Why?
|
Cohort Studies | 2 | 2016 | 41317 | 0.010 |
Why?
|
DNA, Viral | 1 | 2008 | 2195 | 0.010 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2001 | 57 | 0.010 |
Why?
|
Epiglottis | 1 | 2001 | 81 | 0.010 |
Why?
|
Superior Vena Cava Syndrome | 1 | 2001 | 57 | 0.010 |
Why?
|
DNA | 1 | 1995 | 7236 | 0.010 |
Why?
|
Computer Simulation | 1 | 2014 | 6210 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2010 | 6543 | 0.010 |
Why?
|
Pregnancy | 3 | 1998 | 29725 | 0.010 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2927 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6067 | 0.010 |
Why?
|
Genetic Variation | 1 | 2013 | 6540 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2013 | 12762 | 0.010 |
Why?
|
Quality of Life | 1 | 2018 | 13300 | 0.010 |
Why?
|
Risk Assessment | 1 | 2017 | 24086 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2012 | 9388 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2003 | 21065 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2017 | 15680 | 0.010 |
Why?
|
Binding Sites, Antibody | 1 | 1995 | 337 | 0.010 |
Why?
|
Incidence | 1 | 2012 | 21378 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2013 | 15766 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 1995 | 286 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1995 | 871 | 0.010 |
Why?
|
False Positive Reactions | 1 | 1994 | 956 | 0.010 |
Why?
|
Mice, Mutant Strains | 1 | 1995 | 1760 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 1995 | 1694 | 0.010 |
Why?
|
Pregnancy Trimester, Second | 1 | 1994 | 732 | 0.010 |
Why?
|
Chromosome Disorders | 1 | 1994 | 499 | 0.010 |
Why?
|
Maternal Age | 1 | 1994 | 807 | 0.010 |
Why?
|
United States | 1 | 2018 | 72363 | 0.010 |
Why?
|
Radioimmunoassay | 1 | 1988 | 866 | 0.000 |
Why?
|
Ultrasonography, Prenatal | 1 | 1994 | 1745 | 0.000 |
Why?
|
Gestational Age | 1 | 1994 | 3564 | 0.000 |
Why?
|
Genetic Testing | 1 | 1994 | 3530 | 0.000 |
Why?
|
Risk Factors | 1 | 1994 | 74269 | 0.000 |
Why?
|